Background: � Considerable resources have been dedicated to reducing the rate of MRSA infections.� One frequently-employed infection control tool is surveillance testing among patients not known to be MRSA colonized.� This process is costly, and false-positive tests lead to isolation of non-carriers.� This technique would improve if patients at high risk of colonization could be readily identified for testing using an automated system.
Objective: � To derive and validate automatable prediction rules for identifying patients at high risk for MRSA colonization at the time of hospital admission, and to compare them to previously published models.
Methods: � MRSA-colonization prediction rules were designed using only
prospectively collected electronic data resident in a patient's electronic
medical record (EMR) within a day of admission.�
The strategies for developing the rules were as follows: 1) �Comprehensive'
rule � any variables resident in the EMR; 2) �Parsimonious' rule � only
variables remaining after those with P >
0.01 were removed in stepwise fashion from the �Comprehensive' model; 3)
�Clinician Entry' rule � only variables readily available to an admitting
physician after meeting a patient for the first time; 4) �Simple EMR' rule �
only variables available to a rudimentary EMR based on registration,
laboratory, and admission-discharge-transfer data; 5) �Centers for Disease
Control and Prevention (CDC) Risk Factor' rule � only simple-to-obtain
variables that have been strongly identified with healthcare-associated MRSA
colonization in the past.� Rules were derived using
multivariable modeling in a population of 23,314 patients consecutively
admitted and tested for MRSA colonization at a
Results: � MRSA admission prevalence was 2.2% and 4.0% in the derivation and validation cohorts respectively.� Multivariable modeling identified independent predictors of MRSA colonization among demographic, admission-related, pharmacological, laboratory, physiological and historical variables.� The five prediction rules varied in their performance, but all could be used to identify the 30% of patients who accounted for more than 60% of all MRSA colonization, and about 70% of all MRSA patient-days (see Figure for �Comprehensive' rule performance).� All rules could also identify the 20% of patients with a >8% chance of colonization, and the 40% of patients in whom colonization prevalence was 2% or less.� The new rules outperformed 2 published prediction rules (Figure).
Conclusions: � We report prediction rules that can be used to automate the triage
of patients for MRSA admission testing.�
The efficiencies introduced by these rules could result in substantial
cost savings to infection control programs with potentially little sacrifice in
program effectiveness.